Agomelatine

Agomelatine is a novel antidepressant acting as a melatonin receptor agonist (MT1/MT2) and a serotonin receptor antagonist (5-HT2C). It resynchronizes circadian rhythms and improves sleep quality. Mediocon Inc supplies pharmaceutical-grade Agomelatine for licensed pharmaceutical manufacturers.

Key Features

• Unique melatonergic antidepressant
• EP compliant quality
• Circadian rhythm resynchronization
• Improved tolerability vs classical antidepressants

Applications

• Major depressive disorder tablets
• Circadian rhythm disorder treatment
• Insomnia-associated depression
• Specialty CNS formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings